7 | CannabinoidsIBA
01/2015
-
12/2007 |
6 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2018
-
12/2007 |
5 | EndocannabinoidsIBA
01/2015
-
01/2006 |
4 | AM4113IBA
02/2013
-
12/2007 |
3 | 9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA
08/2013
-
01/2013 |
2 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
12/2018
-
03/2013 |
2 | Paclitaxel (Taxol)FDA LinkGeneric
12/2018
-
09/2012 |
2 | Opioid Analgesics (Opioids)IBA
12/2018
-
02/2013 |
2 | Morphine (MS Contin)FDA LinkGeneric
12/2018
-
02/2013 |
2 | AM 251 (AM251)IBA
01/2015
-
12/2007 |
2 | RimonabantIBA
03/2013
-
02/2013 |
2 | Mesylates (Mesylate)IBA
02/2013
-
01/2013 |
1 | cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
12/2018 |
1 | fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
12/2018 |
1 | diphenyl (biphenyl)IBA
12/2018 |
1 | URB937IBA
12/2018 |
1 | Therapeutic UsesIBA
12/2018 |
1 | LeptinIBA
01/2015 |
1 | CorticosteroneIBA
01/2015 |
1 | Insulin (Novolin)FDA Link
01/2015 |
1 | GlucocorticoidsIBA
01/2015 |
1 | SCH 23390IBA
02/2013 |
1 | Haloperidol (Haldol)FDA LinkGeneric
02/2013 |
1 | pyrazoleIBA
02/2013 |
1 | quinolineIBA
02/2013 |
1 | Dopamine (Intropin)FDA LinkGeneric
02/2013 |
1 | Methamphetamine (Desoxyn)FDA LinkGeneric
02/2013 |
1 | methanandamideIBA
02/2013 |
1 | Naltrexone (ReVia)FDA LinkGeneric
02/2013 |
1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2013 |
1 | 3- (1- hexylcyclobut- 1- yl)- 6a,7,8,9,10,10a- hexahydro- 6,6- dimethyl- 6H- dibenzo(b,d)pyran- 1,9 diolIBA
01/2013 |
1 | Cisplatin (Platino)FDA LinkGeneric
09/2012 |
1 | 3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA
09/2012 |
1 | plerixaforFDA Link
09/2012 |
1 | Glucose (Dextrose)FDA LinkGeneric
08/2010 |
1 | LipidsIBA
08/2010 |
1 | LigandsIBA
03/2008 |
1 | Pharmaceutical PreparationsIBA
03/2008 |
1 | EmeticsIBA
12/2007 |
1 | Appetite Depressants (Anorectics)IBA
12/2007 |